NaviNet is a free, Internet-based application for providers to streamline data exchanges between their offices and Highmark. The waiver of Highmark member cost-sharing for in-network telehealth visits is effective for electrolysis amerigroup of service from March 13 international claims June 30, Please carefully read and follow the instructions contained within the individual form for submission. Health Options Provider Manual. Medical Policy Medical Policy. This partnership is instrumental in bringing a personalized care transitions approach to support Highmark's Medicare Advantage members across Pennsylvania and West Virginia. Contact Us.
SP Survey to assess electronic nicotine device use and readiness to quit among college students. RP Evaluation of the utilization of Saxenda liraglutide and bariatric services on patients within a health system.
SP Adverse effects associated with oxymetazoline treatment in FDA adverse event reporting system. RP Clinical and economic impact of procalcitonin testing at an academic tertiary care medical center. RP-2 Evaluation of transdermal fentanyl patch utilization in a community hospital setting. F Anticoagulation for venous thromboembolism prophylaxis in COVID patients: assessment of prescribing practices and adverse events.
RP Impact of pharmacy-driven interventions on antibiotic therapy for patients with gram negative bacteremia. University of Colorado Skaggs School of Pharmacy. A Case Report. SP-6 Analysis of state political party control in relation to pharmacy legislation, cancer epidemiology, infant mortality, and per-capita healthcare expenditures. University of Louisiana Monroe College of Pharmacy. University of Maryland Eastern shore school of pharmacy.
RP Retrospective review of post-operative opioid reduction secondary to pre-operative gabapentin use in patients undergoing bariatric surgery. SP Improving fragmented care with a collaborative pharmacy practice model.
SP Evaluation of common reasons for delayed initial hepatitis B immunization in two academic neonatal intensive care units. FF Impact of the implementation of shared medical appointments in a veteran population receiving chronic opioid therapy. SP Are broad-spectrum antibiotics always necessary to treat patients? Piperacillin-tazobactam usage at a community teaching hospital. RP Diabetic ketoacidosis — treatment simplified, standardized, and successful at your hospital too. Midwestern University Chicago College of Pharmacy.
P Predictors of inappropriate prescribing in patients with renal impairment. P Drug dosing in patients with renal impairment. RP Impact of an interdisciplinary heart failure clinic versus usual care on patient outcomes.
University of the Pacific, Thomas J. Long School Of Pharmacy. RP Management of hyperkalemia with insulin and dextrose using a pharmacist developed order set to identify, monitor, and treat hypoglycemia. P Evaluating naloxone use in a Lebanese tertiary care teaching hospital. RP Reducing opioid use in bariatric surgery at an acute care medical center. RP Implementation of pharmacogenomic testing in a rural ambulatory clinic. RP-3 Sepsis alert early indicator in the emergency department: effect on antibiotic timing - a quasi-experimental review.
SP Evaluation and characterization of intravenous iron use in the inpatient setting. RP Evaluation of potential cost-savings associated with fixed dose 4-factor prothrombin complex concentrate use. RP Therapeutic enoxaparin dosing in obese patients. RP-2 Standardization of emergency department metrics to determine pharmacist impact. SP The impact of glucagon-like peptide-1 agonists as add-on therapy in patients with type 2 diabetes mellitus.
SP Trends in post-operative opioid usage with the introduction of a multimodal pain management approach for adult surgical patients in a rural hospital setting. RP Safety and appropriateness of antimicrobial usage in elderly patients with asymptomatic bacteriuria. RP Evaluation of enhanced recovery after surgery ERAS protocol implementation in colorectal surgery and total knee replacement at a community teaching hospital.
P Clinical safety and efficacy of amisulpride for the prevention of postoperative nausea and vomiting in patients receiving opioid analgesia: data from a phase III trial. SP Precision of medication therapy problem identification and classification amongst primary care clinic pharmacists. RP-3 The impact of a pharmacist driven chronic medication management clinic on chronic disease management, cost minimization and patient satisfaction in a rural health system. SP Ciprofloxacin-Induced Seizure.
RP Impact of a pharmacist-led transitions of care program on chronic obstructive pulmonary disease exacerbation readmission rates. SP Evaluation of injectable calcitonin use for the treatment of hypercalcemia at an urban academic medical center. RP Effect of a multiplex gastrointestinal panel on medication management. FF Comparison of hypoglycemia-related emergency department visit rates in older adults with type 2 diabetes mellitus on different classes of antidiabetic medications.
RP Evaluation of appropriate vancomycin prescribing for the prevention of newborn group B streptococcal infections in a community hospital obstetrics service. SP The care given to a psychiatrically ill patient transitioning from a psychiatric facility into hospice care.
RP Impact of a clinical pharmacy multiple sclerosis service in optimizing quality patient care and affordability. Methodist Hospital and Methodist Children's Hospital. RP Evaluation of vancomycin discontinuation within 72 hours of empiric therapy initiation at a large community hospital. RP Impact of social media education on antimicrobial stewardship awareness among medical, pharmacy and nursing students and residents.
SP-2 Use of amantadine to improve recovery of consciousness in patients with nontraumatic intracranial hemorrhage. SP Assessment of the incidence of proteinuria and hypertension with an accelerated infusion time of bevacizumab-awwb and a comparison to bevacizumab. RP Evaluation of albumin utilization in an adult inpatient setting. University of Southern California School of Pharmacy. RP Impact of therapeutic substitutions on hospitalized patients: A retrospective observational study of unexpected medication order activities at discharge.
RP Assessing fluoroquinolone use in patients with a history of aortic dissection or aortic aneurysm. SP Pharmacy led tobacco cessation program. SP Evaluation of benzodiazepine dosing for treatment of seizures in an academic medical center emergency department.
RP Practicality, utility, and awareness of risk assessment tools in the emergency department. SP Molecular modeling in cardiovascular research: pharmacophore evaluation of sodium channel blockers. SP Evaluation of glucose control and hypoglycemia with a continuous glucose monitor in patients with diabetes being seen by an ambulatory care clinical pharmacist.
RP Evaluation of pharmacologic treatment for alcohol use disorder AUD in behavioral health inpatients. SP Analyzing a pharmacist lead bedside delivery service at discharge in a rehabilitation hospital. FF Antimicrobial agents prescribing trend in patients admitted for pneumonia during the coronavirus pandemic. SP Evaluating weight-based norepinephrine dosing in critically ill patients at an academic medical center.
P Impact of transitions of care pharmacists on hospital readmission rates. P-2 Attitudes and beliefs of patients towards community pharmacy services. P Community pharmacists clinical intervention to reduce pharmaceutical waste. P Establishment of a direct-patient pharmacist intervention within an interdisciplinary team in paediatric oncology.
P Clinical reasoning of community pharmacists for self-care recommendations. SP An interprofessional simulation: improving transitions of care and reducing medical errors. RP Evaluation of opioid prescribing in coronary artery bypass patients following opioid stewardship interventions. FF Effects of antidepressants on anti-diabetic medication adherence in patients with uncontrolled diabetes mellitus and depression. P Impact of an antimicrobial stewardship program on pharmaceutical costs.
RP Evaluation of prescribing practices of four-factor prothrombin complex concentrate for warfarin-associated bleeding at an academic medical center and potential cost savings with a fixed-dose strategy. RP Impact of body mass index on the anticoagulation effect of direct-acting oral anticoagulants in patients admitted to an academic medical center: a retrospective cohort study. RP Evaluate the utilization of synthetic angiotensin II in septic or distributive shock.
SP Development of a pharmacy-based evaluation tool to assess medication causality for inpatient fall events. RP Assessing rates and influencing factors of nonadherence specialty medications in a Medicaid managed care organization. SP Evaluation of erythromycin and azithromycin as gastric motility agents in post-esophagectomy patients.
SP Assessment of opioid exposure during intensive care unit ICU visitations contributing to opioid epidemic post-discharge. SP Evaluation of a pharmacy assistance program on day heart failure readmission rates. SP A comprehensive review of infection control methods for viral-mediated gene therapy in a healthcare setting. University of Illinois at Chicago- College of Pharmacy. SP Analysis of opioid-related harms associated with inpatient fentanyl patch administration.
RP Effect of propofol on vasopressor use in septic patients. P Determining the proportion of patients with low-risk pulmonary embolism who can be managed safely as an out-patient. RP Impact of fixed- versus weight-based initial fluid resuscitation for sepsis in patients with congestive heart failure. SP Retrospective review of ceftriaxone utilization in a community teaching hospital.
SP Evaluation of venous thromboembolism prophylaxis VTE in cancer patients admitted to a community hospital. SP Analysis on the effect of clinical and geriatric elements on prescribing patterns of oral anticoagulation therapy in atrial fibrillation.
RP The impact of pharmacist-driven intervention on improving use of sedation in mechanically ventilated patients in the ICU. SP Assessment of outcomes with pharmacy-driven inpatient chronic obstructive pulmonary disease COPD management process. FF Effect of clinical pharmacy specialists on prescription of diabetes medications with cardiovascular benefit.
SP Safety and efficacy of apixaban following bioprosthetic valve replacements: a retrospective evaluation. SP Clinical outcomes with remdesivir for the treatment of covid hospitalized patients in an academic institution. FF Impact of the implementation of a polypharmacy deprescribing tool in a virtual geriatric outpatient clinic.
RP The true cost of biosimilars: a look at cost-discrepancy and reimbursement rates for biologic transitions in a rural hospital setting. SP Comparing the use of sotalol versus dofetilide in patients hospitalized for symptomatic atrial fibrillation: A retrospective analysis. SP Evaluation of bendamustine dose adjustments or delays in patients receiving concurrent trimethoprim-sulfamethoxazole for pneumocystis jiroveci pneumonia prophylaxis.
SP Rare case of gonococcal infective endocarditis. SP-9 Subcutaneous heparin use for venous thromboembolism prophylaxis over enoxaparin in patients with creatinine clearance greater than 30 milliliters per minute. RP Impact of emergency medicine pharmacist involvement on door to needle tPA time and patient outcomes in acute ischemic stroke.
RP Evaluation of QTc prolongation and other adverse events associated with droperidol use. SP Closing the circle: preliminary results on the impact of pharmacy intern anticoagulation services on patient care at a tertiary pediatric center.
Intermountain Healthcare Primary Children's Hospital. RP Evaluating empiric antibiotics in pediatric patients in a cardiac intensive care unit. RP Development of a medication utilization dashboard to rapidly inform dynamic sterile anticipatory compounding and distribution strategies for COVID specific medications.
SP Use of atropine as a premedication for the prevention of cholinergic side effects in patients treated with irinotecan. FF High-dose opioid tapering and discontinuation medication use evaluation. SP Evaluation of glucagon-like peptide-1 receptor agonists for the treatment of non-alcoholic fatty liver disease NAFLD in non-diabetic and diabetic patients. SP Correlation between taxane hypersensitivity reactions and outcomes in patients with breast and gynecologic cancer.
SP Comprehensive evaluation of a medication delivery and distribution model. RP Optimizing medication use to decrease wholesale acquisition cost WAC purchases in a five-hospital health system. RP Retrospective study to evaluate 4-point major adverse cardiovascular events in patients with type 2 diabetes and cardiovascular disease treated with glucagon-like peptide 1 receptor agonists. SP Evaluation of pneumococcal vaccine administration during pharmacist-led annual wellness visits AWV.
SP Evaluation of the relationship between hypoalbuminemia and oral anti-cancer drug toxicity in adult patients with renal cell carcinoma. RP Impact of over-resuscitation in septic patients presenting to the emergency department.
RP Evaluating the use and prescribing practice of scheduled short acting opioids for pain management within an academic hospital setting.
SP Evaluation of student perceptions of online modular courses following an unanticipated change to online learning at a college of pharmacy. RP Comparison of programmed intermittent epidural boluses and continuous epidural infusions for maintenance of labor analgesia. SP Determining factors associated with loss to follow-up in new patients with type two diabetes mellitus. RP Assessing medication waste in an inpatient hospital pharmacy. SP Polymyxin B for the treatment of Acinetobacter bacteremia: a case series.
RP Pharmacist involvement in promoting safe prescribing practices of benzodiazepines to improve patient safety and quality measures in a primary care setting. RP Impact of pharmacist driven patient education on acute coronary syndrome patient outcomes. SP Effects of amantadine on individuals with dementia-related behaviors. SP High risk characteristics of a chronic obstructive pulmonary disease population in a rural family medicine clinic. RP Evaluation of methadone use to create policies for best practice.
FF Improving provider compliance querying state prescription drug monitoring programs in a Veterans health care system — a quality improvement project. SSS A collaborative approach to professional development. RP Development of gene therapy standard operating procedure in a five-hospital health system. SP Pediatric aminoglycoside dosing and monitoring evaluation PADME : A retrospective chart review of pharmacokinetic protocol at a pediatric teaching hospital.
RP Use of sodium bicarbonate as adjunctive treatment in severe diabetic ketoacidosis. Midwestern University College of Pharmacy-Glendale. SP Student pharmacist education initiative: advocating thromboembolism risk and oral contraceptives as the pharmacist's role expands. RP Evaluation and implementation of clinical pharmacy services in the outpatient pharmacy infusion setting. RP Analysis of the utilization, efficacy, and safety of cefprozil in patients with acute uncomplicated diverticulitis.
RP Safety of fondaparinux for acute coronary syndromes in patients with severe renal impairment. RP Retrospective institutional evaluation of clinical decision support tool implementation on vancomycin dosing outcomes. RP Evaluation of unfractionated heparin dosing by anti-Xa monitoring during targeted temperature management post cardiac arrest. RP Assessment of prophylactic antibiotic use in patients with delayed sternal closure post cardiothoracic surgery.
RP-4 Symptom free pee, let it be: effect of a microbiology comment nudge on asymptomatic bacteriuria ASB. SP Incidence of hypoglycemia when insulin has been administered by intravenous push for the treatment of hyperkalemia. SP Pharmacist impact on hypertension management in the primary care setting. FF Improving hyperglycemia management in hospitalized patients at a VA hospital. SP Evaluation of venous thromboembolism prophylaxis, venous thromboembolisms, and bleeding in patients with an elevated international normalized ratio.
RP Optimizing therapy and outcomes in persistent methicillin-resistant Staphylococcus aureus bloodstream infections. RP Rasburicase medication use evaluation. SP Hepatitis B screening practices in rituximab patients at a large academic medical center: retrospective evaluation of medication use and literature review.
FF Evaluation of a population health tool to improve utilization of clinical pharmacy specialists in the primary care setting. Joseph Campus. FF Combining prescriber-directed interventions with patient and prescriber education to reduce outpatient antibiotic prescribing for acute uncomplicated bronchitis. RP Assessing clinical outcomes of empiric cephalexin therapy for the treatment of uncomplicated urinary tract infections UTIs. SP Describing learner perspectives of quality educators to inform preceptor development design.
SP Obesity as a pharmacokinetic factor in patient response to amiodarone. RP Pharmacist led initiative to improve bone health screening in older persons with human immunodeficiency virus HIV. RP Expansion of pharmacist clinical services to optimize the management of gout in a veterans affairs medical center.
SP Meropenem drug utilization evaluation in a bed community teaching hospital. RP Evaluation of the effect of sepsis diagnosis and screening tools on the duration of antibiotics in patients admitted through the emergency department.
SP Evaluation of a modified adult diabetic ketoacidosis protocol on hypoglycemia rates in a community hospital ICU. RP Antimicrobial stewardship opportunities for intravenous IV to oral PO conversion in pediatric patients with intra-abdominal infections. RP Fixed versus weight-based dosing of four-factor prothrombin complex concentrate in patients requiring reversal of direct oral anticoagulant or warfarin-associated anticoagulation: a retrospective observational study.
RP Evaluation of length of therapy of ceftriaxone use in hospitalized patients with pneumonia. RP A multimodal approach to targeting chair time in a community cancer center infusion suite. RP Impact of dual antibiotic prophylaxis on sternal wound infections in cardiac surgery patients.
SP The appropriate use of psychotropics in the management of hemophilia in a patient with schizoaffective disorder and HIV: A case report. RP Incidence of cytomegalovirus infection in renal transplant recipients receiving valganciclovir as cytomegalovirus prophylaxis. SP Evaluation of adverse drug reaction formatting in drug information mobile applications. SP Utilization of medication products in a pediatric operating room. P Implementation of a protocol-driven pharmacy technician approved refill process at a large physician network.
RP Hospital length of stay in patients initiated on warfarin versus direct oral anticoagulants in atrial fibrillation and venous thromboembolism. SP Evaluating the medication-use process following the addition of William S.
Middleton Memorial Veterans Hospital. FF Evaluation of an interdisciplinary nurse practitioner and clinical pharmacy specialist heart failure access clinic.
SP Evaluating the success and satisfaction of minority students through a non-profit, guided professional development and mentoring program. RP Financial assessment of labor spend regarding implementation of flex staffing at an academic medical center. RP Financial and clinical outcomes from implementation of medication therapy management services performed by clinical pharmacists in the primary care setting.
FF Treatment outcomes for opioid use disorder in the emergency department: a medication use evaluation. RP-4 Impact of resuming antidepressants and antipsychotics on delirium incidence in the intensive care unit. SP Bleeding risk in morbidly obese postpartum patients receiving enoxaparin for venous thromboembolism prophylaxis. RP Evaluating the impact of pharmacist-driven education on appropriate treatment of asymptomatic bacteriuria.
Philadelphia College of Osteopathic Medicine - Georgia. RP Impact of pharmacist -led intravenous insulin protocol in controlling blood glucose levels in surgical cardiac patients at a tertiary care cardiac center in Saudi Arabia. RP Implementation of an outpatient antibiotic stewardship program. RP Characterization of vasopressor de-escalation practices in the medical intensive care unit.
Skaggs School of Pharmacy, University of Montana. SP Successful bilateral electroconvulsive therapy in a patient with a seizure disorder taking levetiracetam, lorazepam, and zonisamide: a case report. Shenandoah University - Bernard J. Dunn School of Pharmacy. SP Impact of removing limitations on intravenous hydralazine use in a community hospital.
P Pharmacy technician driven prior authorization processing in an academic health system. RP Comparison of dosing errors for tenecteplase vs alteplase for management of acute ischemic stroke. RP Analyzing the effects of automated dispensing cabinet inventory review standardization in inpatient adult units: a pre vs post study.
RP Use of an electronic database to evaluate performance of anticoagulation. SP Retrospective evaluation of the effectiveness of GLP-1 agonists in real-world patient population with type 2 diabetes. RP Modafinil for wakefulness in ischemic stroke. SP Factors influencing nimodipine dose modification in aneurysmal subarachnoid hemorrhage.
SP Evaluation of the impact of a chemotherapy induced nausea and vomiting pharmacist delegation protocol. RP Evaluating anticoagulation failure in patients with prostate cancer treated with enzalutamide.
SP Discontinuation rates of P2Y12 therapy post-percutaneous coronary intervention. SP Assessing the optimal timeline for type 2 diabetes patients to achieve glycemic goal when receiving endocrinology specialty care in an ambulatory setting.
P Budget impact of intravenous cetirizine hydrochloride for the treatment of acute urticaria in the United States emergency department setting. RP Development and implementation of a pharmacist-led hepatitis C service to increase screening rates and treatment within a primary care setting. RP Unifying therapeutic interchanges in a non-profit, community-directed health system.
SP Evaluation of Medicaid day supply requirement in a long-term care facility for mental health patients. SP Evaluation of bivalirudin use across a multicenter health system. SP Breastfeeding benefits on gastrointestinal health and developing atopic eczema. RP Impact of an outpatient clinical pharmacist on heart failure hospitalizations at a disproportionate share hospital. SP Development of an opioid prescribing report for the opioid stewardship committee at an academic health system.
RP Intravenous bolus versus drip as initial approach for blood pressure in acute ischemic stroke patients receiving tissue-plasminogen activator. RP Antimicrobial regimens for small intestinal bacterial overgrowth in children. RP Retrospective evaluation of appropriate use of antibiotics in inflammatory abdominal syndromes. RP Impact of implementation of an antibiotic side-chain-based cross-reactivity chart in patients with pneumonia.
RP Parenteral nutrition associated cholestasis in preterm neonates: a comparison between soybean-derived and fish oil-containing lipid emulsions. SP Evaluation of bowel regimens used in patients receiving opioid medications at a large rural academic medical center. RP Cardiac monitoring of QTc prolonging agents in hospitalization. RP Apixaban use in patients with atrial fibrillation and end-stage renal disease requiring hemodialysis.
RP Evaluation of premixed insulin safety and efficacy within a large community teaching hospital. RP Analyzing the impact of medication therapy problem resolution on glycemic control through pharmacist-led state of emergency telehealth during the COVID pandemic. SP Analysis of intranasal versus oral administration of midazolam for procedural anxiolysis in pediatric emergency department patients.
SP Procalcitonin impact on antibiotic discontinuation. RP Effect of vancomycin-exposure on incidence of vancomycin-associated acute kidney injuries. RP Diabetic therapy in type 2 diabetic patients with clinical atherosclerotic cardiovascular disease in a Family Medicine Clinic: An analysis of guideline compliance.
RP Identification of clinical factors that determine empiric antibiotic use in low risk, preterm neonates. RP Optimizing automation and workflow design using an operational mission and vision statement. RP Retrospective evaluation of diabetic ketoacidosis treatment utilizing a two-bag versus one-bag system.
University of Montana Skaggs School of Pharmacy. RP Safety and efficacy of direct oral anticoagulants versus conventional anticoagulant therapy in cancer patients with venous thromboembolism.
SP Assessment of rebound fractures after discontinuation of denosumab. RP Evaluation of the use of dexmedetomidine for benzodiazepine refractory alcohol withdrawal.
RP Impact of pharmacist involvement on the utility of a gram-negative blood culture identification panel on antimicrobial usage in a community hospital.
The University of Mississippi School of Pharmacy. SP Objectives: destination or journey? RP Evaluation of high-dose infliximab in the treatment of inflammatory bowel disease IBD in adults. P Buprenorphine initiation for opioid use disorder in the emergency department at a community based, academic, level 1 trauma center: a pilot study. RP Evaluation and description of nimodipine use in aneurysmal subarachnoid hemorrhage aSAH in a community hospital neuroscience intensive care unit.
SP Assessing health literacy of patient handouts for hypothyroidism. RP Vasopressin-induced hyponatremia in infants: a retrospective case-control. RP Evaluating the mortality benefit of using either normal saline or lactated ringer in patients who are septic. SP Faculty and student perceptions of telehealth cases versus objective structure clinical examinations. RP Prophylactic enoxaparin dosing for trauma patients. RP-5 Novel pharmacy practice model in the management of treatment resistant depression.
RP Evaluation of norepinephrine dose and vasopressin utilization in patients with septic shock. RP Evaluation of a pharmacist-led, high-risk medication consultation service for geriatric trauma patients at a level-1 trauma center.
RP Unfractionated heparin dosed using adjusted body weight in an obese population. Julie Gowda Foundation Manager. Jami Gertz Actress. Rebecca Barel Kimpton Fellow. Darcy Anderson Development Consultant. Show all 12 coworkers of Mary Mosteller. Job title Director of Philanthropic Partnerships. Job functions Entrepreneurship. LinkedIn profile linkedin. Company The Giving Back Fund. Founded in Industry Philanthropy.
What company does Mary Mosteller work for? Mary works for The Giving Back Fund. What are Mary Mosteller's current job functions? Mary Mosteller's job functions are Entrepreneurship, Operations. What is Mary Mosteller's email address? What is Mary Mosteller's LinkedIn profile? Which College did Mary Mosteller attend? Mary Mosteller's most recent education was at E b am l et mo tan in e at a sa at.
Although we have been serving the Southern Tier since , each spring the staff at CareFirst feels even more blessed to work and live in such a generous community. Nearly individuals sold over 15, geraniums for hospice this year. Just as hospice has touched so many hearts, our geranium sale truly reaches thousands of your friends and neighbors who beautify both personal and corporate landscapes, while honoring loved ones who have left this earth.
As your nonprofit provider of hospice, palliative care and grief services in Chemung, Schuyler, and Steuben counties, CareFirst takes pride in providing excellence in end of life care and grief support when families need it most.
It is our honor and privilege to provide dignified, compassionate care to the terminally ill and grieving. Safe, effective, rapid-acting care for chronic pain. Non-Invasive Post-Stroke Recovery. We now have the newest and the most advanced TMS Technology available. Your therapy can be complete in less than 20 minutes a day!
Appointments Available Within 48 Hours! The initial evaluation and all TMS treatment is covered with most commercial insurance plans and Medicare, Medicaid. We also offer Spanish and Arabic Translators. New Brunswick, NJ carefirstmedicalgroup gmail.
Contact Us Comments or Questions for Us? If you have comments or questions, we want to help you. For technical support, call the CareFirst Help Desk at () – Below is a list . Web[Maryland and WDC] Offers healthcare insurance to residents of Maryland and Washington, DC. Information for Brokers, employers, and providers, as well as links to Missing: email. Web Meads Creek Road Painted Post, NY [email protected]: email.